Syed Ali

Syed Ali is an Associate Professor in the Department of Biomedical Sciences at Nazarbayev University's School of Medicine. He joined Nazarbayev University in 2015 after previously working at The Aga Khan University across Pakistan, Kenya, and Afghanistan. His research focuses on viral evolution and drug screening against oncogenic viruses.

• PhD in Virology (1999) from Roswell Park Cancer Institute and State University of New York
• Post-doctoral training (1999-2003) at Harvard Medical School and Dana-Farber Cancer Institute

Dr. Ali's research spans viral evolution and drug development against oncogenic viruses. His primary focus is on HIV, HPV, HCV, and HBV, with particular emphasis on immune evolution in high-risk populations across Pakistan, Afghanistan, Nepal, and Kenya. His laboratory has developed cell culture models and patented enzyme assays for testing antiviral drugs and vaccines. The research also employs bioinformatics tools to study viral transmission patterns and phylogeny in different populations.

Analysis of Dr. Ali's publications reveals a strong focus on viral epidemiology in Central and South Asia, particularly studies of HIV transmission dynamics in high-risk groups including injection drug users, men who have sex with men, migrants, and refugees. His work combines molecular virology with epidemiological approaches to understand viral evolution and drug resistance patterns. Recent publications show increasing focus on Kazakhstan as a research location, particularly regarding HIV and HCV epidemiology in the post-Soviet context.

• Extensive research on HIV molecular epidemiology across multiple countries
• Studies on viral co-infections and drug resistance patterns
• Development of antiviral drug screening methods
• Investigation of viral epitope evolution in different populations

Dr. Ali has supervised PhD and Master's students in Virology, Oncology, Bioinformatics, and Drug Design. His educational contributions include designing undergraduate and graduate courses in critical thinking, virology, oncology, and film criticism. He is recognized as an expert in e-learning and has developed massive open online courses (MOOCs) in Drug Discovery, making educational resources more accessible across resource-limited settings.

His laboratory continues active research through multiple funded projects examining HIV transmission dynamics, drug resistance mutations, and viral evolution patterns in Kazakhstan and surrounding regions. Current projects include analysis of HIV-1 Pol epitopes, whole genome sequencing of Hepatitis C virus variants, and identification of emerging HIV infection hotspots using integrated phylodynamic-epidemiologic approaches.